Glenmede Trust CO Na Myriad Genetics Inc Transaction History

Glenmede Trust CO Na

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$12.16 - $19.77 $25,523 - $41,497	-2,099 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$11.25 - $14.75 $270 - $354	-24 Reduced 1.13%	2,099 $27,000
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $23,026 - $35,519	-2,154 Reduced 50.36%	2,123 $24,000
Q4 2019 Feb 12, 2020	SELL	$20.93 - $35.1 $39,390 - $66,058	-1,882 Reduced 30.56%	4,277 $116,000
Q3 2019 Nov 14, 2019	BUY	$22.08 - $47.08 $2,406 - $5,131	109 Added 1.8%	6,159 $175,000
Q1 2019 May 14, 2019	SELL	$26.93 - $34.7 $22,324 - $28,766	-829 Reduced 12.05%	6,050 $200,000
Q4 2018 Feb 14, 2019	BUY	$27.23 - $45.56 $187,315 - $313,407	6,879 New	6,879 $199,000
Q3 2018 Nov 15, 2018	SELL	$37.57 - $50.34 $88,101 - $118,047	-2,345 Closed	0 $0
Q2 2018 Nov 05, 2018	SELL	$27.75 - $40.17 $6,743 - $9,761	-243 Reduced 9.39%	2,345 $87,000
Q2 2018 Aug 15, 2018	BUY	$27.75 - $40.17 $5,328 - $7,712	192 Added 8.01%	2,588 $96,000
Q4 2017 Feb 15, 2018	BUY	$28.45 - $37.14 $6,913 - $9,025	243 Added 11.29%	2,396 $81,000
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $51,693 - $77,938	2,153	2,153 $0

232

92.6M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $2.13B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.